Coherus Biosciences reported $5.67M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
AbbVie USD 5.31B 178M Sep/2026
Acadia Pharmaceuticals USD 40.36M 68.31M Sep/2026
Akebia Therapeutics USD 18.7M 5.68M Sep/2026
ALKERMES USD 261.1M 37.86M Sep/2026
Alnylam Pharmaceuticals USD 105.91M 8.8M Sep/2026
Amarin USD 158.85M 5.22M Sep/2026
Amgen USD 6.39B 169M Sep/2026
Baxter International USD 2.3B 41M Sep/2026
Biogen USD 2.22B 159.9M Sep/2026
BioMarin Pharmaceutical USD 1.8B 13.54M Sep/2026
Bristol-Myers Squibb USD 2.7B 33M Sep/2026
Coherus Biosciences USD 5.67M 842K Jun/2026
Eli Lilly USD 18.19B 1.4B Sep/2026
Fujifilm JPY 600.8B 678M Mar/2026
Gilead Sciences USD 1.9B 57M Sep/2026
Merck USD 6.16B 43M Sep/2026
Myriad Genetics USD 30.6M 2.7M Jun/2026
Pacira USD 3.83B 3.69B Sep/2026
Perrigo USD 1.01B 50.7M Sep/2026
Pfizer USD 10.02B 77M Sep/2026
PTC Therapeutics USD 109.33M 17.98M Sep/2026
Regeneron Pharmaceuticals USD 2.89B 189.7M Sep/2026
Sarepta Therapeutics USD 876.12M 28.15M Sep/2026
Teva Pharmaceutical Industries USD 3.17B 48M Sep/2026
Vertex Pharmaceuticals USD 2.25B 480.2M Sep/2026
Zoetis USD 2.54B 38M Sep/2026